Patent details

EP2566967 Title: CADHERIN-11 ANTAGONIST FOR THE TREATMENT OF FIBROSIS

Basic Information

Publication number:
EP2566967
PCT Application Number:
PCT/US/2011/035110
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117782334
PCT Publication Number:
WO/2011/140173
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CADHERIN-11 ANTAGONIST FOR THE TREATMENT OF FIBROSIS
French Title of Invention:
ANTAGONISTE DE LA CADHÉRINE-11 POUR LE TRAITEMENT DE LA FIBROSE
German Title of Invention:
CADHERIN-11-ANTAGONISTEN ZUR BEHANDLUNG VON FIBROSE
SPC Number:

Dates

Filing date:
04/05/2011
Grant date:
06/07/2016
EP Publication Date:
06/07/2016
PCT Publication Date:
10/11/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/03/2013
EP B1 Publication Date:
06/07/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/05/2017
Expiration date:
04/05/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/05/2011
 
 

Name:
Board of Regents The University of Texas System
Address:
201 West 7th Street, Austin, TX 78701, United States (US)

Name:
The Brigham and Women's Hospital Inc.
Address:
75 Francis Street, Boston, MA 02115, United States (US)

Inventor

1

Name:
SCHNEIDER Daniel, J.
Address:
United States (US)

2

Name:
BRENNER Michael, B.
Address:
United States (US)

3

Name:
AGARWAL Sandeep, K.
Address:
United States (US)

Priority

1

Priority Number:
331355 P
Priority Date:
09/01/2001
Priority Country:
United States (US)

2

Priority Number:
331357 P
Priority Date:
04/05/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/113;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages